Submission for Danish Health Authority Consultation on Gender Incongruence Professional Framework and Guidance

Introduction

Genspect welcomes the opportunity to provide a detailed analysis of two key documents recently issued by the Danish Health Authority:

1. “Professional framework for healthcare assistance in gender incongruence”, which establishes the organizational structure and professional requirements for gender services in Denmark, including referral pathways, assessment protocols, and treatment frameworks.
2. “Guidance on Health Professional Assistance in Gender Incongruence”, which outlines specific requirements regarding care and conscientiousness in treatment delivery, as well as provisions for information and consent.

Response to “Professional framework for healthcare assistance in gender incongruence”

Overview

The Professional Framework establishes organizational structures and requirements for gender services in Denmark. A notable shift is the framework’s terminology change from “gender dysphoria” to “gender incongruence,” removing the emphasis on distress or dysphoria as a prerequisite for treatment. This change appears to lower the clinical threshold for intervention, diverging from other countries that are adopting more cautious approaches. While the framework demonstrates attention to detail in multidisciplinary team requirements and clinical pathways, several aspects raise substantial concerns about patient safeguarding and evidence-based care.

Evidence Base and Treatment Protocol Concerns

The framework makes crucial acknowledgments about evidence limitations warranting serious consideration. Section 5.4 explicitly states “there is still only sparse evidence regarding the long-term effects of medical treatment for gender incongruence in children and adolescents.” Regarding adult treatment, Section 6.4 claims there is “some evidence for a beneficial effect of medical treatment,” yet notably admits this evidence “does not reflect the heterogeneous group that currently seeks medical treatment.”

Despite these acknowledged limitations, the framework proceeds to outline medical intervention protocols. While requiring research competencies within teams and ongoing research monitoring (Section 4.1), these provisions seem insufficient given the experimental nature of many interventions. The framework’s allowance of cross-sex hormones from age 15, with provisions for earlier treatment if delay would be “medically irresponsible,” raises particular concerns given the evidence limitations.

Organizational Structure and Safeguarding

Key areas warranting enhancement include:

1. While psychological support is identified as “essential throughout the process” (Section 5.1), the framework does not mandate extended exploratory therapy periods before medical interventions
2. Provisions for managing co-occurring conditions require strengthening, particularly given the acknowledgment that “a significant portion of children and adolescents with incongruence between sex assigned at birth and gender identity also have a developmental disorder” (Section 5.3)
3. The framework’s approach to detransition support lacks sufficient detail
4. More specific protocols are needed for systematic collection of long-term outcome data

Recommendations for Enhancement

1. Evidence and Research Requirements

• Establish rigorous protocols for systematic long-term outcome data collection
• Require comprehensive tracking of physical and mental health impacts
• Mandate documentation of detransition rates and experiences
• Create standardized quality of life assessment tools
• Institute regular external outcome review

2. Assessment and Treatment Protocols

• Require extended exploratory therapy periods before medical interventions
• Establish specific criteria for “medically irresponsible” treatment delay
• Create detailed protocols for neurodivergent individuals
• Strengthen mental health assessment requirements
• Institute mandatory minimum waiting periods between stages

3. Safeguarding Enhancements

• Develop comprehensive detransition support protocols
• Create specific guidance for complex co-occurring conditions
• Establish clearer psychological readiness criteria
• Institute regular independent case reviews
• Require ongoing psychological support

Response to “Guidance on Health Professional Assistance in Gender Incongruence”

Overview

The guidance establishes standards for direct clinical care delivery, with particular focus on consent, documentation, and clinical responsibilities. While comprehensive in many areas, several aspects warrant enhancement to ensure optimal patient care.

Treatment Risk Acknowledgment and Consent Framework

The guidance appropriately acknowledges in Section 1 that treatments are “largely irreversible, long-lasting and particularly regarding lower surgery, there is a high incidence of complications.” However, the consent framework requires strengthening in several areas:

1. Information Requirements

• While Section 3.2 provides detailed requirements for information provision, more emphasis should be placed on discussing alternative approaches
• The experimental nature of many interventions should be more explicitly addressed
• Long-term implications for fertility and sexual function warrant more detailed discussion

2. Clinical Responsibility and Documentation

• Though MDT management is required, specific protocols for recording dissenting opinions would strengthen oversight
• More detailed requirements needed for documenting treatment progression rationale
• Enhanced protocols required for monitoring and responding to complications
• Clearer criteria needed for treatment modification or discontinuation

3. Communication Protocols

• More specific guidance needed for neurodivergent individuals
• Extended reflection periods required between information provision and consent
• Enhanced requirements for documenting patient understanding
• Clearer protocols for ongoing communication throughout treatment

Recommendations for Enhancement

1. Consent and Information Protocols

• Develop standardized information packages covering all treatment alternatives
• Institute mandatory extended reflection periods
• Create specialized consent protocols for complex cases
• Establish clear documentation requirements for patient understanding

2. Clinical Oversight Mechanisms

• Implement systematic adverse event reporting
• Create detailed MDT decision documentation templates
• Establish clear criteria for treatment modifications
• Require regular independent clinical audits

3. Communication and Support Framework

• Develop specialized communication protocols for diverse patient needs
• Create comprehensive follow-up schedules
• Establish clear pathways for addressing complications
• Institute regular patient feedback mechanisms

Conclusion

The Danish Health Authority’s guidelines represent a significant effort to establish comprehensive frameworks for gender-related healthcare. However, our analysis identifies three critical areas requiring enhancement:

1. Evidence Foundation The acknowledged limitations in evidence, particularly regarding long-term outcomes, necessitate more robust research protocols and systematic data collection across all services.
2. Clinical Governance Given the irreversible nature of many interventions, stronger safeguarding measures and clearer decision-making protocols are essential, particularly for complex cases and vulnerable populations.
3. Patient Support While the framework recognizes the importance of comprehensive care, more structured requirements for ongoing support and clear pathways for all treatment outcomes, including detransition, are needed.

While these documents attempt to create a framework for gender-related healthcare delivery, their approach remains concerning given the acknowledged evidence limitations and irreversible nature of interventions. The emphasis on medical pathways is particularly troubling given the increasing numbers of detransitioners and the emerging evidence from other countries that are now taking more cautious approaches. We strongly urge the Danish Health Authority to reconsider this medicalized approach and instead prioritize exploratory psychotherapy and support that addresses underlying distress without rushing to irreversible interventions. Genspect remains committed to advocating for evidence-based care that prioritizes long-term patient wellbeing and safety above all else.